168 related articles for article (PubMed ID: 25613235)
1. Between-session and within-session habituation in Prolonged Exposure Therapy for posttraumatic stress disorder: a hierarchical linear modeling approach.
Sripada RK; Rauch SA
J Anxiety Disord; 2015 Mar; 30():81-7. PubMed ID: 25613235
[TBL] [Abstract][Full Text] [Related]
2. Habituation of distress and craving during treatment as predictors of change in PTSD symptoms and substance use severity.
Badour CL; Flanagan JC; Gros DF; Killeen T; Pericot-Valverde I; Korte KJ; Allan NP; Back SE
J Consult Clin Psychol; 2017 Mar; 85(3):274-281. PubMed ID: 28221062
[TBL] [Abstract][Full Text] [Related]
3. Harm expectancy violation during exposure therapy for posttraumatic stress disorder.
de Kleine RA; Hendriks L; Becker ES; Broekman TG; van Minnen A
J Anxiety Disord; 2017 Jun; 49():48-52. PubMed ID: 28399468
[TBL] [Abstract][Full Text] [Related]
4. Does Traumatic Brain Injury Attenuate the Exposure Therapy Process?
Ragsdale KA; Gramlich MA; Beidel DC; Neer SM; Kitsmiller EG; Morrison KI
Behav Ther; 2018 Jul; 49(4):617-630. PubMed ID: 29937262
[TBL] [Abstract][Full Text] [Related]
5. Are 60-minute prolonged exposure sessions with 20-minute imaginal exposure to traumatic memories sufficient to successfully treat PTSD? A randomized noninferiority clinical trial.
Nacasch N; Huppert JD; Su YJ; Kivity Y; Dinshtein Y; Yeh R; Foa EB
Behav Ther; 2015 May; 46(3):328-41. PubMed ID: 25892169
[TBL] [Abstract][Full Text] [Related]
6. In session extinction and outcome in Virtual Reality Exposure Therapy for PTSD.
Rauch SAM; Koola C; Post L; Yasinski C; Norrholm SD; Black K; Rothbaum BO
Behav Res Ther; 2018 Oct; 109():1-9. PubMed ID: 30059794
[TBL] [Abstract][Full Text] [Related]
7. Changes in Salivary Cortisol During Psychotherapy for Posttraumatic Stress Disorder: A Pilot Study in 30 Veterans.
Rauch SAM; King AP; Liberzon I; Sripada RK
J Clin Psychiatry; 2017 May; 78(5):599-603. PubMed ID: 28102979
[TBL] [Abstract][Full Text] [Related]
8. Affective lability predicts decreased habituation in posttraumatic stress symptom responding during a single laboratory session of imaginal exposure.
Dutton CE; Badour CL; Jones AC; Mischel ER; Feldner MT
J Anxiety Disord; 2016 Oct; 43():52-57. PubMed ID: 27517669
[TBL] [Abstract][Full Text] [Related]
9. Cortisol augmentation of a psychological treatment for warfighters with posttraumatic stress disorder: Randomized trial showing improved treatment retention and outcome.
Yehuda R; Bierer LM; Pratchett LC; Lehrner A; Koch EC; Van Manen JA; Flory JD; Makotkine I; Hildebrandt T
Psychoneuroendocrinology; 2015 Jan; 51():589-97. PubMed ID: 25212409
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of Change in Written Exposure Treatment of Posttraumatic Stress Disorder.
Wisco BE; Baker AS; Sloan DM
Behav Ther; 2016 Jan; 47(1):66-74. PubMed ID: 26763498
[TBL] [Abstract][Full Text] [Related]
11. Fear activation and habituation patterns as early process predictors of response to prolonged exposure treatment in PTSD.
van Minnen A; Hagenaars M
J Trauma Stress; 2002 Oct; 15(5):359-67. PubMed ID: 12392223
[TBL] [Abstract][Full Text] [Related]
12. Extinction learning as a moderator of d-cycloserine efficacy for enhancing exposure therapy in posttraumatic stress disorder.
de Kleine RA; Smits JA; Hendriks GJ; Becker ES; van Minnen A
J Anxiety Disord; 2015 Aug; 34():63-7. PubMed ID: 26121495
[TBL] [Abstract][Full Text] [Related]
13. Emotional Activation and Habituation During Imaginal Exposure for PTSD Among Women With Borderline Personality Disorder.
Harned MS; Ruork AK; Liu J; Tkachuck MA
J Trauma Stress; 2015 Jun; 28(3):253-7. PubMed ID: 26062135
[TBL] [Abstract][Full Text] [Related]
14. PATTERNS OF CHANGE IN RESPONSE TO PROLONGED EXPOSURE: IMPLICATIONS FOR TREATMENT OUTCOME.
Clapp JD; Kemp JJ; Cox KS; Tuerk PW
Depress Anxiety; 2016 Sep; 33(9):807-15. PubMed ID: 27321062
[TBL] [Abstract][Full Text] [Related]
15. Repeated trauma exposure does not impair distress reduction during imaginal exposure for posttraumatic stress disorder.
Jerud AB; Farach FJ; Bedard-Gilligan M; Smith H; Zoellner LA; Feeny NC
Depress Anxiety; 2017 Aug; 34(8):671-678. PubMed ID: 27921349
[TBL] [Abstract][Full Text] [Related]
16. A multi-level modeling approach examining PTSD symptom reduction during prolonged exposure therapy: moderating effects of number of trauma types experienced, having an HIV-related index trauma, and years since HIV diagnosis among HIV-positive adults.
Junglen AG; Smith BC; Coleman JA; Pacella ML; Boarts JM; Jones T; Feeny NC; Ciesla JA; Delahanty DL
AIDS Care; 2017 Nov; 29(11):1391-1398. PubMed ID: 28266223
[TBL] [Abstract][Full Text] [Related]
17. Augmenting treatment efficiency in exposure therapy for PTSD: a randomized double-blind placebo-controlled trial of yohimbine HCl.
Tuerk PW; Wangelin BC; Powers MB; Smits JAJ; Acierno R; Myers US; Orr SP; Foa EB; Hamner MB
Cogn Behav Ther; 2018 Sep; 47(5):351-371. PubMed ID: 29448886
[TBL] [Abstract][Full Text] [Related]
18. Patterns and predictors of subjective units of distress in anxious youth.
Benjamin CL; O'Neil KA; Crawley SA; Beidas RS; Coles M; Kendall PC
Behav Cogn Psychother; 2010 Jul; 38(4):497-504. PubMed ID: 20509987
[TBL] [Abstract][Full Text] [Related]
19. How Much Is Enough? Trauma Recall and the Exposure Therapy Process.
Morrison KI; Beidel DC; Bowers CA
J Nerv Ment Dis; 2020 Mar; 208(3):215-221. PubMed ID: 31904667
[TBL] [Abstract][Full Text] [Related]
20. The pattern of symptom change during prolonged exposure therapy and present-centered therapy for PTSD in active duty military personnel.
Brown LA; Clapp JD; Kemp JJ; Yarvis JS; Dondanville KA; Litz BT; Mintz J; Roache JD; Young-McCaughan S; Peterson AL; Foa EB;
Psychol Med; 2019 Sep; 49(12):1980-1989. PubMed ID: 30220261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
